0001055726-23-000033.txt : 20230516 0001055726-23-000033.hdr.sgml : 20230516 20230516164847 ACCESSION NUMBER: 0001055726-23-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230513 FILED AS OF DATE: 20230516 DATE AS OF CHANGE: 20230516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANSEY ROGER D CENTRAL INDEX KEY: 0001741836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 23928323 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wk-form4_1684270114.xml FORM 4 X0407 4 2023-05-13 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001741836 DANSEY ROGER D 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 1 0 0 0 0 Common Stock 2023-05-13 4 M 0 12000 A 24000 D Common Stock 2023-05-16 4 M 0 19000 A 43000 D Restricted Stock Unit 2023-05-13 4 M 0 12000 0 D Common Stock 12000 12000 D Common Stock Options 0.77 2023-05-15 4 A 0 35000 0 A 2033-05-15 Common Stock 35000 35000 D Restricted Stock Unit 2023-05-15 4 A 0 26000 0 A Common Stock 26000 26000 D Restricted Stock Unit 2023-05-16 4 M 0 19000 0 D Common Stock 19000 0 D Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares vested on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023. This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. Options to vest 100% on May 15, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024. /s/ Roger Dansey 2023-05-16